Evidence map›Paper›PMID 41003343›Full record

ArticleJournal of imaging2025

E-CMCA and LSTM-Enhanced Framework for Cross-Modal MRI-TRUS Registration in Prostate Cancer.

Ciliang Shao, Ruijin Xue, Lixu Gu

Abstract read
In one paragraph

Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ciliang ShaoPittsburgh Institute, Sichuan University, Chengdu 610207, China.
Ruijin XuePittsburgh Institute, Sichuan University, Chengdu 610207, China.
Lixu GuPittsburgh Institute, Sichuan University, Chengdu 610207, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate registration of MRI and TRUS images is crucial for effective prostate cancer diagnosis and biopsy guidance, yet modality differences and non-rigid deformations pose significant challenges, especially in dynamic imaging. This study presents a novel cross-modal MRI-TRUS registration framework, leveraging a dual-encoder architecture with an Enhanced Cross-Modal Channel Attention (E-CMCA) module and a LSTM-Based Spatial Deformation Modeling Module. The E-CMCA module efficiently extracts and integrates multi-scale cross-modal features, while the LSTM-Based Spatial Deformation Modeling Module models temporal dynamics by processing depth-sliced 3D deformation fields as sequential data. A VecInt operation ensures smooth, diffeomorphic transformations, and a FuseConv layer enhances feature integration for precise alignment. Experiments on the μ-RegPro dataset from the MICCAI 2023 Challenge demonstrate that our model significantly improves registration accuracy and performs robustly in both static 3D and dynamic 4D registration tasks. Experiments on the μ-RegPro dataset from the MICCAI 2023 Challenge demonstrate that our model achieves a DSC of 0.865, RDSC of 0.898, TRE of 2.278 mm, and RTRE of 1.293, surpassing state-of-the-art methods and performing robustly in both static 3D and dynamic 4D registration tasks.

Indexed as

cross-modal attentiondeep learningfeature fusionlong-short term memoryMRI-TRUS registrationprostate cancer diagnosis

Identifiers

PMID41003343
PMCPMC12471084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.